May 7, 2025 01:00AM
Mar 20, 2025 02:00AM
Mar 26, 2024 02:00AM
Mar 23, 2023 02:00AM
Feb 17, 2023 01:00AM
Dec 1, 2022 01:00AM
Nov 10, 2022 01:00AM Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates
Aug 11, 2022 01:00AM
Aug 8, 2022 04:45PM
Aug 8, 2022 04:45PM
Jun 23, 2022 11:45AM
Jun 20, 2022 01:00AM
Jun 20, 2022 01:00AM
May 5, 2022 01:00AM Valneva Reports Q1 2022 Results and Provides Corporate Updates
Apr 26, 2022 06:45AM
Apr 26, 2022 01:00AM
Mar 24, 2022 02:00AM
Feb 4, 2022 01:00AM
Sep 28, 2021 01:00AM
Aug 10, 2021 01:00AM
Jul 19, 2021 01:00AM Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate
Mar 8, 2021 01:00AM
Feb 25, 2021 01:00AM
Jan 7, 2021 11:45AM
Nov 3, 2020 01:00AM
Aug 4, 2020 01:00AM
May 7, 2020 01:00AM
Apr 30, 2020 01:00AM Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Feb 27, 2020 01:00AM
Oct 31, 2019 02:00AM
Aug 1, 2019 01:00AM
May 2, 2019 01:01AM
Feb 21, 2019 01:01AM
Nov 8, 2018 01:01AM
Aug 2, 2018 01:02AM VALNEVA Delivers Strong IXIARO® Sales Growth and reports Further Progress on Key R&D Programs in H1
May 17, 2018 01:01AM
Mar 22, 2018 02:01AM
Nov 9, 2017 01:02AM
May 11, 2017 01:04AM
Mar 23, 2017 02:02AM
Feb 23, 2017 01:02AM
Nov 9, 2016 01:21AM VALNEVA Reports Strong Business Performance in First Nine Months. Company Raises Financial Guidance for FY 2016
Aug 31, 2016 01:09AM
May 11, 2016 01:12AM
Mar 21, 2016 02:25AM
Feb 24, 2016 01:08AM
Jan 26, 2016 12:09PM
Nov 10, 2015 01:09AM
Aug 31, 2015 01:43AM VALNEVA Reports Strong H1 2015 Revenues
May 12, 2015 01:42AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All